Alteration of TGF-β signalling is a major cause underlying PAH, as mutations in receptors in the TGF-β superfamily are responsible for almost all familial PAH, with BMPR2 alterations being the most prominent [3]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.